02
Mar
As part of President Biden’s historic Inflation Reduction Act, nearly four million seniors on Medicare with diabetes started to see their insulin costs capped at $35 per month this past January, saving some seniors hundreds of dollars for a month’s supply. But in his State of the Union, President Biden made clear that this life-saving benefit should apply to everyone, not just Medicare beneficiaries.This week, Eli Lilly, the largest manufacturer of insulin in the United States is lowering their prices and meeting that call. Eli Lilly announced they are lowering the cost of insulin by 70% and capping what patients pay out-of-pocket…